These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8357331)

  • 1. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.
    Zughaib ME; Sun JZ; Bolli R
    Basic Res Cardiol; 1993; 88 Suppl 1():155-67. PubMed ID: 8357331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ischemic potential of drugs related to the renin-angiotensin system.
    Ertl G; Hu K
    J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S11-20. PubMed ID: 11392474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.
    Przyklenk K; Kloner RA
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):167S-175S. PubMed ID: 2690907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist on metabolism and contraction in ischemia-reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 2000 Apr; 64(4):276-82. PubMed ID: 10783050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
    Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
    J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: role of bradykinin and nitric oxide.
    Kitakaze M; Node K; Takashima S; Minamino T; Kuzuya T; Hori M
    Hypertens Res; 2000 May; 23(3):253-9. PubMed ID: 10821135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction?
    Przyklenk K; Kloner RA
    Basic Res Cardiol; 1993; 88 Suppl 1():139-54. PubMed ID: 8357329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of converting enzyme inhibitors on myocardial ischemia and reperfusion injuries].
    Galinier M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():99-104. PubMed ID: 8304819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model.
    Kobara M; Tatsumi T; Kambayashi D; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Fushiki S; Nakagawa M
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):880-9. PubMed ID: 12775965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion.
    Brunner F; Kukovetz WR
    Circulation; 1996 Oct; 94(7):1752-61. PubMed ID: 8840871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.